Skip to main content

Advertisement

SpringerLink
Log in

Regulation of cell growth by interferon

  • Published:
Cancer and Metastasis Reviews Aims and scope Submit manuscript

Abstract

Interferons can regulate growth and differentiation in a wide range of cell types. These mechanisms are currently being examined. Interferons inhibit the growth of tumour cells and are thus potential anti-cancer agents. They can also inhibit normal cell growth in vitro, and stimulate tumour cell growth in vitro. They may also be involved in some autoimmune discases. This review examines the effect of interferons on cell proliferation, function, and growth, focusing primarlily on in vitro cell systems.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Isaacs A, Lindenmann J: Virus interference. 1. The interferon. Proc R Soc London (Biol) 147: 258–267, 1957

    Google Scholar 

  2. Paucker K, Cantell K, Henle W: Effect of interfering viruses and interferon on the growth rate of cells. Virology 17: 324–334, 1962

    Google Scholar 

  3. Knight E: Antiviral and cell growth inhibitory activities reside in the same glycoprotein of human fibroblast interferon. Nature (Lond) 262: 302–303, 1976

    Google Scholar 

  4. Gresser I, DeMacyer-Guignard J, tovey MG, DeMacyer E: Electrophoretically pure mouse interferon exerts multiple biological effects. Proc Natl Acad Sci USA 76: 5308–5312, 1979

    Google Scholar 

  5. Evinger M, Rubinstein M, Pestka S: Antiproliferative and antiviral activities of human lcukocyte interferons. Arch Biochem Biophys 210: 319–329, 1981

    Google Scholar 

  6. Evinger M, Macda S, Pestka S: Recombinant human leukocyte interferon produced in bacteria has antiproliferative activity. J Biol Chem 256: 2113–2114, 1981

    Google Scholar 

  7. Atanasiu P, Chany C: Action d'un interferon provenant de cellules malignes, sur l'infection experimentale du hamster nouvcau-né par le virus du polyome. CR Acad Sci Paris 251: 1687–1689, 1960

    Google Scholar 

  8. Gresser I, Tovey MG: Antitumour effects of interferon. Biochim Biophys Acta 516: 231–247, 1978

    Google Scholar 

  9. Chany C, Vignal M: Stude du mecanisme de l'état réfractaire des cellules a la production d'interferon, après inductions répétées. CR Acad Sci Paris 267: 1798–1800, 1968

    Google Scholar 

  10. Aguct M: High affinity binding of 125I-labelled mouse interferon to a specific cell surface receptor. Nature 284: 459–461, 1980

    Google Scholar 

  11. Gresser I, Maury G, Brouty-Boye D: Mechanism of antitumour effect of interferon in mice. Nature 239: 167–168, 1972

    Google Scholar 

  12. Lindahl P, Leary P, Gresser I: Enhancement by interferon of the specific cytotoxicity of sensitized lymphocytes. Proc Natl Acad Sci USA 69: 721–725, 1972

    Google Scholar 

  13. Lindahl-Magnusson P, Leary P, Gresser I: Interferon inhibits DNA synthesis induced in mouse lymphocyte suspensions by phytohaemoglutinin or by allogeneic cells. Nature New Biol 237: 120–125, 1972

    Google Scholar 

  14. Friedman RM, Vogel SN: Interferons with special emphasis on the immune system. Adv Immunol 34: 97–140, 1983

    Google Scholar 

  15. Taylor-Papadimitriou J: The effects of interferon on the growth and function of normal and malignant cells. In: Burke DC, Morris AG (eds) Interferons: from Molecular Biology to Clinical Application. Cambridge University Press, Cambridge, 1983, pp 109–147

    Google Scholar 

  16. Stewart WE II, Blalock JE, Burke DC, Chany C, Dunnick JK, Falcoff E, Friedman RM, Galasso GJ, Joklik WK, Vilcek JT, Younger JS, Zoon KC: Interferon nomenclature. Nature 286: 110, 1980

    Google Scholar 

  17. Stewart WEII, Blalock JE, Burke DC, Chany C, Dunnick JK, Falcoff E, Friedman RM, Galasso GJ, Joklik WK, Vilcek JT, Younger JS, Zoon KC: Interferon nomenclature. J Int Res 1: vi-vii, 1981

    Google Scholar 

  18. Nagata S, Brack C, Henco K, Shambock A, Weissman C: Partial mapping of genes of the human interferon α family. J Int Res 1: 333–336, 1981

    Google Scholar 

  19. Weissman C, Nagata S, Boll W, Fountoulakis M, Fujisawa A, Fujisawa J-J, Haynes J, Henco K, Mantei N, Ragg H, Schein C, Schmid J, Shaw G, Streuli M, Taira H, Todokoro K, Weidle U: Structure and expression of human alpha-interferon genes. UCLA Symp Mol and Cell Biol XXV, Merigan TC, Friedman RM (eds) Academic Press Inc, New York, 1982, p 295

    Google Scholar 

  20. Collins J: Structure and expression of the human interferon genes. In: Burke DC (ed) Interferons: From Molecular Biology to Clinical Application. Symp Soc Gen Microbiol 35, Cambridge University Press. Cambridge, 1983, pp 35–65

    Google Scholar 

  21. Weissmann C: The cloning of interferon and other mistakes. In: Gresser I (ed) Interferon 3, Academic Press, New York, 1981, p 101

    Google Scholar 

  22. Kingsman SM, Kingsman AJ: The production of interferon in bacteria and yeast. In: Burke DC, Morris AG (eds) Interferons, from Molecular Biology to Clinical Application. Symp Soc Gen Microbiol 35, Cambridge University Press, Cambridge, 1983, pp 211–254

    Google Scholar 

  23. Collins J: Interferon genes: gene structure and elements involved in gene regulation. In: Friedman RM (ed) Interferon 3, Elsevier Science Publishers, B. V. Amsterdam, 1984, pp 33–83

    Google Scholar 

  24. Nagata S, Mantei N, Weissmann C: The structure of one of the eight or more distinct chromosomal genes for human interferon. Nature 287: 401–408, 1980

    Google Scholar 

  25. Goeddel DV, Leung DW, Dull TJ, Gross M, Lawn RM, McCandliss R, Seeburg PH, Ullrich A, Yelverton F, Gray PW: The structure of eight distinct cloned human leukocyte interferon cDNAs. Nature 290: 20–26, 1981

    Google Scholar 

  26. Wetzel R, Levine HL, Estell DA, Shire S, Finer-Moore J, Stroud RM, Bewley TA: Structure function studies on human alpha-interferon. UCLA Symp Mol Cell Biol XXV, Academic Press, 1982, pp 365–376

  27. Levy WP, Rubinstein M, Shively J, DelValle U, Lai C-Y, Moschera J, Brink L, Gerber L, Stein S, Pestka S: Amino acid sequence of a human lcukocyte interferon. Proc Natl Acad Sci USA 78: 6186–6190, 1981

    Google Scholar 

  28. Arnheiter H, Ohno M, Smith ME, Gutte B, Zoon KC: Orientation of a human leukocyte interferon molecule on its cell surface receptor: carboxy terminus remains accessible to a monoclonal antibody made against a synthetic interferon peptide. Proc Natl Acad Sci USA 80: 2539–2543, 1983

    Google Scholar 

  29. Capon DJ, Shepard HM, Goeddel DV: Two distinet families of human and bovine interferon-α genes are coordinately expressed and encode functional polypeptides. Mol Cell Biol 5: 768–779, 1985

    Google Scholar 

  30. Sehgal PB, Sagar AD: Heterogencity of poly (I) Poly (c) induced human fibroblast interferon mRNA species. Nature 288: 95–97, 1980

    Google Scholar 

  31. Weissenbach J, Chernajovsky Y, Zeevi M, Schulman L, Soreg H, Nir V, Wallach D, Perricaudet M, Tiollais P, Revel M: Two interferon mRNAs in human fibroblasts: in vitro translation and Escherichia coli cloning studies. Proc Natl Acad Sci USA 77: 7152–7156, 1980

    Google Scholar 

  32. Ohlsson M, Feder J, Cavalli S, Sforza LL, VonGabain A: Close linkage of α and β interferons and infrequent duplication of interferon in humans. Proc Natl Acad Sci USA 82: 4473–4476, 1985

    Google Scholar 

  33. Leung DW, Capon DJ, Goeddel DV: The structure and bacterial expression of 3 distinct bovine interferon-beta genes. Biotechnol 2: 458, 1984

    Google Scholar 

  34. Yip YK, Vilcek J: Production of human fibroblast interteron in the presence of the glycosylation inhibitor tunicamycin. Meth Enzymol 78: 212–220, 1981

    Google Scholar 

  35. McCormick F, Frahey M, Innis M, Dieckmann B, Ringold G: Inducible expression of amplified human beta interferon genes in CHO cells. Mol Cell Biol 4: 166–172, 1984

    Google Scholar 

  36. Rinderknecht E, O'Connor BH, Rodriguez H: Natural human interferon γ. J Biol Chem 259: 6790–6797, 1984

    Google Scholar 

  37. Streuli M, Hall A, Boll W, StewartII WE, Nagata S, Weissmann C: Target cell specificity of human interferon alpha produced in Escherichia coli and hybrid molecules derived from them. Proc Natl Acad Sci USA 78: 2848–2852. 1981

    Google Scholar 

  38. Mizoguchi J, Pitha PM, Raj NBK: Efficient expression in Escherichia coli of 2 species of human interferon-alpha and their hybrid molecules. DNA 4: 221–232, 1985

    Google Scholar 

  39. Rehberg E, Kelder B, Hoal EG, Pestka S: Specific molecular activities of recombinant and hybrid leukocyte interferons. J Biol Chem 257: 11497–11502, 1982

    Google Scholar 

  40. Edge MD, Greene AR, Heatheliffe GR, Meacock PA, Schuch W, Scanlon DB, Atkinson TC, Newton CR, Markham AF: Total synthesis of a human leukocyte interferon gene. Nature 292: 736–761, 1981

    Google Scholar 

  41. Alton K, Stabinsky Y, Richards R, Ferguson B, Goldstein L, Altrock B, Miller L, Stebbing N: Production, characterisation and biological effects of recombinant DNA derived human IFN-α and IFN-γ analogs. In: DeMaeyer E, Schellekens H (eds) Biology of the Interferon System. Elsevier Science Publishers B, Amsterdam, 1983, p 119

    Google Scholar 

  42. Gocddel DV, Yelverton E, Ullrich A, Heyneker HL, Miozzari E, Holmes W, Seeburg PH, Dull T, May L, Stebbing N, Crea R, Maeda S, McCandliss R, Sloma A, Tabor JM, Gross M, Familletti PC, Pestka S: Human leukocyte interferon produced by E, coli is biologically active. Nature 287: 411–416, 1980

    Google Scholar 

  43. StewartII WE, Sarkar F, Taira H, Hall A, Nagata S, Weissmann C: Comparisons of several biological and physicochemical properties of human leukocyte interferons produced by human leukocytes and by F. coli. Gene 11: 181–186, 1980

    Google Scholar 

  44. Berg K, Hokland M, Heron J: Biological activities of pure HuIFN-α species. In: Munk K, Kirchner H (eds) Contributions to Oncology 11, Basle, 1982, p 118

  45. Weck PK, Apperson S, May L, Stebbing N: Comparison of the antiviral activities of various clones human interferon α subtypes in mammalian cell cultures. J Gen Virol 57: 233–237, 1981

    Google Scholar 

  46. Taylor-Papadimitriou J, Shearer M, Balkwill FR, Fantes KH: Effects of HuIFN-α2 and HuIFN-α (Namalwa) on breast cancer cells grown in culture and as xenografts in the nude mouse. J Inter Res 2: 479–485, 1982

    Google Scholar 

  47. Balkwill FR, Goldstein L, Stebbing N: Differential action of six human interferons against two human carcinomas growing in nude mice. Int J Cancer 35: 613–617, 1985

    Google Scholar 

  48. Adams A, Strander H, Cantell K: Sensitivity of Epstein-Barr virus transformed human lymphoid cell lines to interferon. J Gen Virol 28: 207–217, 1975

    Google Scholar 

  49. Masucci M, Szigeti R, Klein E, Klein G, Gruest J, Montagnier L, Taira H, Hall H, Nagata S, Weissmann C: Effect of interferon-α1 from E. coli on some cell functions. Science 209: 1431–1438, 1980

    Google Scholar 

  50. Fantes KH, Allen G: Specific activity of pure human interferons and a non biological method for estimating the purity of highly purified interferon preparations. J Inter Res 1: 465–474, 1981

    Google Scholar 

  51. Borden EC, Hogan TF, Voelkel JC: Comparative antiproliferative activity in vitro of natural interferons α and β for diploid and transformed human cells. Cancer Res 42: 4948–4953, 1982

    Google Scholar 

  52. Pfeffer LM, Tamm I: Comparison of the effects of alpha and beta interferons on the proliferations and volume of human tumour cells (HeLa-33. Daudi, P3HR-1). J Inter Res 3: 395–408, 1983

    Google Scholar 

  53. Ruben BY, Gupta SI: Differential efficacies of human type I and type II interferons as antiviral and antiproliferative agents. Proc Natl Acad Sci USA 77: 5928–5932, 1980

    Google Scholar 

  54. Tyring S, Klimpel GR, Fleischmann R, Baron S: Direct cytolysis by partially purified preparations of immune interferon. Int J Cancer 30: 59–64, 1982

    Google Scholar 

  55. Crane Jr JL, Glasgow LA: Kern ER, Younger JS: Inhibition of murine osteogenic sarcomas by treatment with Type I or Type II interferon. J Natl Cancer Inst 61: 871–874, 1978

    Google Scholar 

  56. DeClercq E, Zhang Z-X, Huygen K, Leyter R: Inhibitory effect of interferon on the growth of spontancous mammary tumours in mice. J Natl Cancer Inst 69: 653–657, 1982

    Google Scholar 

  57. Balkwill FR, Bokhon'ko AI: Differential effects of pure human alpha and gamma interferons on fibroblast cell growth and the cell cycle. Exp Cell Res 155: 190–197, 1984

    Google Scholar 

  58. Weil J, Epstein CJ, Epstein LB, Sedmak JJ, Sabran JL, Grossberg SE: A unique set of polypeptides is induced by γ interferon in addition to those induced in common with α and β interferons. Nature 301: 437–439, 1983

    Google Scholar 

  59. Dianzani F, Salter L, Fleischmann WR, Zucca M: Immune interferon activates cells more slowly than does virus-induced interferon. Proc Soc Exp Biol Med 159: 94–97, 1978

    Google Scholar 

  60. Dianzani F, Zucca M, Scupham A, Georgiades JA: Immune and virus induced interferons may activate cells by different derepressional mechanisms. Nature 283: 400–402, 1980

    Google Scholar 

  61. Czarniccki CW, Fennie CW, Powers DB, Estell DA: Synergistic antiviral and antiproliferative activities of Escherichia coli derived human alpha, beta and gamma interferons. J Virol 49: 490–496, 1984

    Google Scholar 

  62. Fleischmann WR, Schwarz LA, Fleischmann CM: Requirement for IFN gamma in potentiation of interferon's antiviral and anticellular activities: identity of mouse and human systems. J Inter Res 4: 265–274, 1984

    Google Scholar 

  63. Gresser I: On the varied biological effects of interferon. Cell Immunol 34: 406–415, 1977

    Google Scholar 

  64. Strander H, Einhorn S: Effect of human leukocyte interferon on the growth of human osteosarcoma cells in tissue culture. Int J Cancer 19: 468–473, 1977

    Google Scholar 

  65. Greenberg P, Mosney S: Cytotoxic effects of interferon in vitro and granulocytic progenitor cells. Cancer Res 37: 1794–1799, 1977

    Google Scholar 

  66. Van'tHull EV, Schellekens H, Lowenberg B, deVries M: Influence of interferon preparations on the proliferative capacity of human and mouse bone marrow cells in vitro. Cancer Res 38: 911–914, 1978

    Google Scholar 

  67. Shibata H, Taylor-Papadimitriou J: Effects of human lymphoblastoid interferon on cultured breast cancer cells. Int J Cancer 28: 447–453, 1981

    Google Scholar 

  68. Balkwill F, Watling D, Taylor-Papadimitriou J: Inhibition by lymphoblastoid interferon of growth of cells derived from the human breast. Int J Cancer 22: 258–265, 1978

    Google Scholar 

  69. Pfeffer LM, Murphy JS, Tamm I: Interferon effects on the growth and division of human fibroblasts. Exp Cell Res 121: 111–120, 1979

    Google Scholar 

  70. Epstein LB, Lee SHS, Epstein CJ: Enhanced sensitivity of Trisomy 21 monocytes to the maturation-inhibiting effect of interferon. Cell Immunol 50: 191–194, 1980

    Google Scholar 

  71. Balkwill F, Oliver RJD: Growth inhibitory effects of interferons on normal and malignant human haemopoictic cells. Int J Cancer 20: 500–505, 1977

    Google Scholar 

  72. Bradley EC, Ruscetti FW: Effect of fibroblast, lymphoid and mycloid interferons on human tumour colony formation. Cancer Res 41: 244–249, 1981

    Google Scholar 

  73. Salmon SE, Duric BGM, Young L, Liu RM, Trown PW, Stebbing N: Effects of cloned human leukocyte interferons in the human tumour stem cell assay. J Clin Oncol 1: 217–225, 1983

    Google Scholar 

  74. Creasey AA, Bartholomew JC, Merigan TC: Role of Go-GI arrost in the inhibition of tumour cell growth by interferon. Proc Natl Acad Sci USA 77: 1471–1475, 1980

    Google Scholar 

  75. Lasfargues EY, Ozello L: Cultivation of human breast carcinomas. J Natl Cancer Inst 21: 1131–1147, 1958

    Google Scholar 

  76. Bourne HR, Rozengurt E: An 18000 molecular weight polypeptide induces early events and stimulates DNA synthesis in cultured cells. Proc Natl Acad Sci USA 73: 4555–4559, 1976

    Google Scholar 

  77. DeLarco LE, Todaro GJ: Growth factors for murine sarcoma virus-transformed cells. Proc Natl Acad Sci USA 75: 4001–4005, 1978

    Google Scholar 

  78. Todaro GJ, Fryling C, DeLarco JE: Transforming growth factors produced by certain human tumour cells: polypeptides that interact with epidermal growth factor. Proc Natl Acad Sci USA 77: 5258–5262, 1980

    Google Scholar 

  79. Taylor-Papadimitriou J, Shearer M, Rozengurt E: Inhibitory effect of interferon on cellular DNA synthesis: modulation by pure mitogenic factors. J Inter Res 1: 401–409, 1981

    Google Scholar 

  80. Taylor-Papadimitriou J, Rozengurt E: Modulation of interferons inhibitory effect on cell growth by the mitogenic stimulus. Texas Rep Biol Med 41: 509–516, 1982

    Google Scholar 

  81. Collyn d'Hooghe MC, Brouty-Boye D, Malaise EP, Gresser I: Interferon and cell division. XII Prolongation by interferon of the intermitotic time of mouse mammary tumour cells in vitro. Exp Cell Res 105: 73–75, 1977

    Google Scholar 

  82. Panniers LRV, Clemens MJ: Inhibition of cell division by interferon: changes in cell cycle characteristics and in morphology of Ehrlich ascites tumour cells in culture. J Cell Sci 48: 259–279, 1981

    Google Scholar 

  83. Killander D, Lindahl P, Lundin L, Leary P, Gresser I: Relationship between the enhanced expression of histocompatibility L1210 antigens on interferon-treated L1210 cells and their position in the cell cycle. Eur J Immunol 6: 56–59, 1976

    Google Scholar 

  84. Matarese GP, Rossi GB: Effect of interferon on growth and division cycle of Freund crythroleukaemic murine cells in vitro. J Cell Biol 75: 344–354, 1977

    Google Scholar 

  85. Lundbaldd D, Lundgren E: Block of a glioma cell line in S by interferon. Int J Cancer 27: 749–754, 1981

    Google Scholar 

  86. Balkwill F, Taylor-Papadimitriou J: Interferonaffects both G1 and S + G2 in cells stimulated from quiescence to growth. Nature 274: 798–200, 1978

    Google Scholar 

  87. Sokawa Y, Watanabe Y, Watanabe Y, Kawade Y: Interferon suppresses the transition of quiescent 3T3 cells to a growing state. Nature 268: 236–238, 1977

    Google Scholar 

  88. Gresser I, Bourali-Maury C. The antitumour effect of interferon in lymphocyte and macrophage-depressed mice. Proc Soc Exp Biol Med 144: 896–900, 1973

    Google Scholar 

  89. Balkwill FR, Taylor-Papadimitriou J, Fantes K, Sebesteny A: Human lymphoblastoid interferon can inhibit the growth of human breast cancer venografts in athymic (nude) mice. Europ J Cancer 16: 569–573, 1980

    Google Scholar 

  90. Balkwill FR, Moodie EM, Freedman V, Fantes KH: Human interferon inhibits the growth of established human breast tumours in the nude mouse. Int J Cancer 30: 231–235, 1982

    Google Scholar 

  91. Balkwill FR, Moodie EM, Mowshowitz S, Fantes KH: An animal model system for investigating the anti-tumour effect of human IFNs on human tumours. In: DeMacyer E, Schellekens H (eds) The Biology of the Interferon System. Elsevier Science Publishers B.V., Amsterdam. 1983, pp 443–448

    Google Scholar 

  92. Balkwill FR, Moodie EM: Positive interactions between human interferon and cyclophosphamide in a human tumour model sytem. Cancer Res 44: 904–909, 1984

    Google Scholar 

  93. Balkwill FR, Mowshowitz S, Seilman SS,Moodie EM, Griffin DB, Fantes KH, Woff CR: Positive interactions between interferon and chemotherapy due to direct tumour action rather than effects on most drug-metabolising enzymes. Cancer Res 44: 5249–5255, 1984

    Google Scholar 

  94. Balkwill FR, Moodie EM, Freedman V, Lane EB, Fantes KH: An animal model system for investigating the antitumour effects of human interferon. J Inter Res 3: 319–326, 1983

    Google Scholar 

  95. Ludwig CU, Durie BGM, Salmon SE, Moon TE: Tumor growth stimulation in vitro by interferons. Eur J Cancer Clin Oncol 19: 1625–1632, 1983

    Google Scholar 

  96. Verhacgen M, Divizia M, Vandenbussche P, Kuwata T, Content J: Abnormal behavior of interferon-induced enzymatic activities in an interferon-resistant cell line. Proc Natl Acad Sci USA 77: 4479–4483, 1980

    Google Scholar 

  97. Panet A, Czarnieeki CW, Falk H, Fricdman RM: Effect of 2′5′-oligoadenylic acid on a mouse cell line partially resistant to interferon. Virology 114: 567–572, 1981

    Google Scholar 

  98. Vandenbussche P, Divizia M, Verhaegen-Lewalle M, Fuse A, Kuwata T, DeClercq E, Content J: Enzymatic activities induced by interferon in human tibroblast cell lines differing in their sensitivity to the anticellular activity of interferon. Virology 111: 11–12, 1981

    Google Scholar 

  99. Silverman RH, Watling D, Balkwill FR, Trowsdale J, Kerr IM: The ppp(A2p)nA and protein kinase systems in wild-type and interferon-resistant Daudi cells. Eur J Biochem 126: 333–341, 1982

    Google Scholar 

  100. Tovey MG, Dron M, Mogensen KE, Lebleu B, Mecht N, Begonlours-Guyamarho J: Isolation of Daudi cells with reduced sensitivity to interferon. II. On the mechanisms of resistance. J Gen Virol 64: 2649–2653, 1983

    Google Scholar 

  101. Vandenbussche P, Kuwata T, Verhaegen-Lewalle M, Content J: Effect of interferon on two human choriocarcinoma-derived cell lines. Virology 128: 474–479, 1983

    Google Scholar 

  102. McMahon M, Kerr IM: The biochemistry of the antiviral state. Symp Soc Gen Microbiol 35, Cambridge University Press, Cambridge, 1983, p 89

    Google Scholar 

  103. Williams BRG, Fish EN: Interferon and viruses: in vitro studies. In: Taylor-Papadimitriou J (ed) Interferons: Their Impact in Science and Medicine. Oxford University Press, Oxford, 1985, pp 40–60

    Google Scholar 

  104. Clemens MJ, Williams BRG: Inhibition of cell-free protein synthesis by pppA2′ p5′-A2p5′: a novel oligonucleotide synthesized by interferon-treated cell extracts. Cell 13: 565–572, 1978

    Google Scholar 

  105. Farrell PJ, Sen GC, Dubois MF, Ratner L, Slattery E, Lengyel P: Interferon action: two distict pathways for inhibition of protein synthesis by double-stranded RNA. Proc Natl Acad Sci USA 75: 5893–5897, 1978

    Google Scholar 

  106. Schmidt A, Zilberstein A, Schulman L, Federman P, Berissi H, Revel M: Interferon action: isolation of nuclease F, a translational inhibitor activated by interferoninduced (2′-5′) oligo-isoadenylate. Febs Lett 95: 257–264, 1978

    Google Scholar 

  107. Shimizu N, Sokawa Y: 2′,5′-oligoadenylate synthetase activity in lymphocytes from normal mouse. J Biol Chem 254: 12034–12037, 1979

    Google Scholar 

  108. Kimchi A, Shure H, Revel M: Regulation of lymphocyte mitogenesis by (2′-5′) oligo-isoadenylate. Nature 282: 849–851, 1979

    Google Scholar 

  109. Burke DC, Graham CF, Lehman JM: Appearance of interferon inducibility and sensitivity during differentiation of murine teratocarcinoma cells in vitro, Cell 13: 243–248, 1978

    Google Scholar 

  110. Wood JN, Hovanessian AG: Interferon enhances 2–5A synthetase in embryonal carcinoma cells. Nature 282: 74–76, 1979

    Google Scholar 

  111. Friedman RL, Manly SP, McMahon M, Kerr IM, Stark GR: Transcriptional and posttranscriptional regulation of interferon induced gene expression in human cells. Cell 38: 745–755, 1984

    Google Scholar 

  112. Fellous A, Ginsberg I, Littauer UZ: Modulation of tubulin mRNA levels by interferon in human lymphoblastoid cells. EMBO J 1: 835–839, 1982

    Google Scholar 

  113. Balkwill FP: The regulatory role of interferons in the human immune response. In: Taylor-Papadimitriou J (ed) Interferons: Their impact in Science and Mcdicine. Oxford University Press, Oxford, 1985, pp 61–80

    Google Scholar 

  114. Friedman RM, Pastan I: Interferon and cyclic 3′,5′-adenosine monophosphate: potentiation of antiviral activity. Biochem Biophys Res Commun 36: 735–740, 1969

    Google Scholar 

  115. Weber JM, Stewart RB: Cyclic AMP potentiation of interferon antiviral activity and effect of interferon on cellular cyclic AMP levels. J Gen Virol 28: 363–372, 1975

    Google Scholar 

  116. Tovey MG, Rochette-Egly C, Castagna M: Effect of interferon on concentrations of cyclic nucleotides in cultured cells. Proc Natl Acad Sci USA 76: 3890–3893, 1979

    Google Scholar 

  117. Schneck J, Rager-Zisman B, Rosen OM, Blum BR: Genetic analysis of the role of cAMP in mediating effects of interferon. Proc Natl Acad Sci USA 79: 1879–1883, 1982

    Google Scholar 

  118. Bannerjce DK, Baksi K, Gottesmann MM: Genetic evidence that action of cAMP-dependent protein kinase is not an obligatory step for antiviral and antiproliferative effects of human interferon in Chinese hamster cells. Virology 129: 230–238, 1983

    Google Scholar 

  119. Ebsworth N, Taylor-Papadimitriou J, Rozengurt E: Cyclic AMP does not mediate inhibition of DNA synthesis by interferon in mouse Swiss 3T3 cells. J Cell Physiol 120: 146–150, 1984

    Google Scholar 

  120. Rozengurt E: Adenosinc receptor activation in quieseent Swiss 3T3 cells: enhancement of cAMP levels. DNA synthesis and cell division. Exp Cell Res 139: 71–78, 1982

    Google Scholar 

  121. Tovey MG: Interferon and eyclie nuclcotides. Interferon 4: 23–46, 1982

    Google Scholar 

  122. Taylor-Papadimitriou J, Rozengurt E: The role of thymidine uptake in the control of cell proliferation. Exp Cell Res 119: 393–398, 1979

    Google Scholar 

  123. Brouty-Roye D, Tovey MG: Inhibition by interferon of thymidine uptake in chemostat cultures of L1210 cells. Intervirol 9: 243–252, 1978

    Google Scholar 

  124. Gewert DR, Shah S, Clemens MJ: Inhibition of cell division by interferons. Changes in the transport and intracellular metabolism of thymidine in human lymphoblastoid (Daudi) cells. Eur J Biochem 116: 487–492, 1981

    Google Scholar 

  125. Mengheri E, Estehan M, Lewis JA: Thymidine kinase genes and the induction of antiviral responses by interferon. Febs Letts 157: 301–305, 1983

    Google Scholar 

  126. Gewert DR, Cohen A, Williams HRG: The effect of interferon on cells deficient in nucleotide transport or lacking thymidine kinase activity. Biochem Biophys Res Commun 118: 124–130, 1984

    Google Scholar 

  127. Rozengurt E: Growth factors, cell proliferation and cancer: an overview. Mol Biol Med 1: 169–181, 1983

    Google Scholar 

  128. Sreevalsan J, Rozengurt E, Taylor-Papadimitriou J, Burchell J: Differential effect of interferon on DNA synthesis, 2-deoxyglucose uptake and ornithine decarboxylase activity in 3T3 cells stimulated by polypeptide growth factors and tumour promoters. J Cell Physiol 104: 1–9, 1980

    Google Scholar 

  129. Lin SS, Ts'o POP, Hollenberg MD: The effects of interferon on epidermal growth factor action. Biochem Biophys Res Commun 96: 168–174, 1980

    Google Scholar 

  130. Taylor-Papadimitriou J, Ebsworth N, Rozengurt E: Possible mechanisms in interferon induced growth inhibition. In: Ford RJ, Maizel AL (eds) Mediators in Cell Growth and Differentiation. Raven Press, New York, 1985, pp 283–298

    Google Scholar 

  131. Sekar V, Atmar VJ, Krim M, Kuchn GD: Interferon induction of polyamine dependent protein kinase activity in Ehrlich ascites tumour cells. Biochem biophys Res Commun 106: 305–311, 1982

    Google Scholar 

  132. Taylor-Papadimitriou J, Balkwill F, Ebsworth N, Rozengurt E: Antiviral and antiproliferative effects of interferons in quieseent fibroblasts are dissociable. Virology 147: 405–412, 1985

    Google Scholar 

  133. Kelly K, Cochran BM, Stiles CD, Leber P: Cell-specific regulation of the c-myc gene by lymphocyte mitogens and platelet-derived growth factor. Cell 35: 603–610, 1983

    Google Scholar 

  134. Einat M, Resnizky D, Kimchi A: Close link between reduction of c-myc expression by interferon and Go/Gl arrest. Nature 313: 597–600, 1985

    Google Scholar 

  135. Ebsworth N, Rozengurt E, Taylor-Papadimitriou J: Microtubule-distrupting agents reverse the inhibitory effect of interferon on mitogenesis in 3T3 cells. Exp Cell Res 165: 255–259, 1986

    Google Scholar 

  136. Wang Z-W, Rozengurt E: Interplay of eyclic AMP and microtubules in modulating the inltiation of DNA synthesis in 3T3 cells. J Cell Biol 96: 1743–1750, 1983

    Google Scholar 

  137. Bourgeaude MF, Chany C: Effect of sodium butyrate on the antiviral and anti-cellular action of interferon on normal and MSV-transformed cells. Int J Cancer 24: 314–318, 1979

    Google Scholar 

  138. Taylor-Papadimitriou J: Effects of interferon on cell growth and function. In: Gresser I (ed) Interferon 2, Academic Press, London, 1980, pp 13–46

    Google Scholar 

  139. Taylor-Papadimitriou J: Effeets of interferon on cell growth and function. In: Billiau A (ed) Elsevier Science Publishers, B.V., Amsterdam, 1984, pp 139–166

    Google Scholar 

  140. Hokland M, Heron I, Berg K: Increased expression of B2-microglobulin and histocompatibillty antigens on human lymphoid cells induced by interferon. J Interferon Res 1: 483–494, 1981

    Google Scholar 

  141. Wallach D, Schattner A, Merlin G, Kimehi A, Fellous M, Revel M: Interferon induced proteins—biological funetions and clinical applications. UCLA Symp Mol Cell Biol 25, Academic Press Inc, New York, 1982, pp 449–463

    Google Scholar 

  142. Revel M, Fellous M, Nir U, Wallach D, Wolf D, Merlin G, Kimchi A: Syhthesis and action of interferon related to the control of cell funetions. J Cell Biochem Suppl 6 (Abstr) 0231: 83, 1982

    Google Scholar 

  143. Wallach D, Fellous M, Revel M: Preferential effect of Interferon on the synthesis of HLA antigens and their mRNAs in human cells. Nature 299: 833–836, 1982

    Google Scholar 

  144. Rosa F, Hata D, Abadie A, Wallach D, Revel M, Fellous M: Differential regulation of HLA-DR mRNAs and cell surface antigens by interferon. EMBO 12: 1585–1589, 1983

    Google Scholar 

  145. Baron S, Isaacs A: Mechanism of recovery from viral infeetion in the chick embryo. Nature 191: 97–98, 1961

    Google Scholar 

  146. Morahan PS, Grossberg SE: Age-related cellular resistance of chicken embryo to viral infections. 1. Interferon and natural resistance to myxoviruses and vesicular stomatitis viruses. J Infect Dis 121: 615–623, 1970

    Google Scholar 

  147. Morahan PS, Grossberg SE: Age-related cellular resistance of chicken embryo to viral infeetions, 2. Inducible resistance produced by influenza virus and Escherichia coli. J Infect Dis 121: 624–633, 1970

    Google Scholar 

  148. Grossberg SE, Morahan PS: L'Interferon, Institut National de la Santé et de la Recherche Médlcale, Paris 1970, p 263

    Google Scholar 

  149. Burke DC: The control of interferon formation. Symp Soc Gen Microbiol 35, Cambridge University Press, Cambridge 1983, pp 67–88

    Google Scholar 

  150. Fowler AK, Reed CD, Giron DJ: Identification of an interferon in murine placentas. Nature 286: 266–267, 1980

    Google Scholar 

  151. Lebon P, Girard S, Thepot F, Chany C: The presence of a interferon in human amniotic fluid. J Gen Virol 59: 393–396, 1982

    Google Scholar 

  152. Keay S, Grossberg SE: Interferon inhibits the conversion of 3T3-L1 mouse fibroblasts into adipocytes. Proc Natl Acad Sci USA 77: 4099–4103, 1980

    Google Scholar 

  153. Rossi GB, Dolei A, Cioc L, Benedetto A, Matarese GP, Belardelli F, Rita G: Interferon and Friend leukemia cells in culture. Tex Rep Biol Med 35: 420–428, 1977

    Google Scholar 

  154. Rossi GB, Dolei A, Cioc L, Benedetto A, Matarese GP, Belardelli F: Inhibition of transcription and translation of globin messenger RNA in dimethyl sulfoxide-stimulated Friend crythroleukemic cells treated with interferon Proc Natl Acad Sci USA 74: 2036–2040, 1977

    Google Scholar 

  155. Beck G, Poindron P, Illinger D, Beck JP, Ebel JP, Falcoff R: Inhibition of steroid inducible tyrosine aminotransferase by mouse and rat interferon in hepatoma tissue culture cells. Febs Lett 48: 297–300, 1974

    Google Scholar 

  156. Illinger D, Coupin G, Richards M, Poindron P: Rat interferon inhibits steroid inducible glycerol 3-phosphate dehydrogenase in a rat glial cell line. Febs Lett 64: 391–395, 1976

    Google Scholar 

  157. Shirasawa N, Matsuno T: Suppression of the accumulation of steroid-inducible glutamine synthetase mRNA on embryonic chick retinal polysomes by interferon preparation. Biochim Biophys Acta 562: 271–280, 1979

    Google Scholar 

  158. Yau PMP, Godefroy-Colburn T, Birge CH, Ramabhadran TU, Thach RE: Specificity of interferon action in protein synthesis. J Virol 27: 648–658, 1978

    Google Scholar 

  159. Friedman RM: Interferon binding: the first step in establishment of antiviral activity. Science 156: 1760–1761, 1967

    Google Scholar 

  160. Chany C: Membrane-bound interferon specific cell receptor system: role in the establishment and amplification of the anti-viral system. Biomedicine 24: 148–157, 1976

    Google Scholar 

  161. Mogensen KE, Bandu M-T, Vignaux F, Aguet M, Gresser I: Binding of 125I-labelled human α interferon to human lymphoid cells. Int J Cancer 28: 575–582, 1981

    Google Scholar 

  162. Branca AA, Baglioni C: Evidence that types I and II interferons have different receptors. Nature 294: 768–770, 1981

    Google Scholar 

  163. Zoon KC, Zur Nedden D Arnheiter H: Specific binding of human α interferon to a high affinity cell surface binding site on bovine kidney cells. J Biol Chem 257: 4695–4697, 1982

    Google Scholar 

  164. Joshi AR, Sarkar PH, and Gupta SL: Interferon receptors: cross linking of human leukocyte interferon α 2 to its receptor on human cells. J Biol Chem 257: 13884–13887, 1982

    Google Scholar 

  165. Anderson P, Yip YK, Vilcek J: Specific binding of 125I-human interferon-gamma to high affinity receptors on human fibroblasts. J Biol Chem 257: 11301–11304, 1982

    Google Scholar 

  166. Tan YH, Tischfield J, Ruddle FH: The linkage of genes for the human interfcron-induced antiviral protein and indophenol oxidase-B traits to chromosome G-21. J Exp Med 137: 317–330, 1973

    Google Scholar 

  167. Chany C, Gregoire A, Vignal M, Lemaitre-Moncuit J, Brown P, Besancon F, Suarez H, Cassingena R. Mechanism of interferon uptake in parental and somatic monkey-mouse hybrid cells. Proc Natl Acad Sci USA 70: 557–561, 1973

    Google Scholar 

  168. Chany C, Vignal M, Couillin P, Nguyen Van Cong, Boue J, Boue A: Chromosomal localization of human genes governing the interferon-induced antiviral state. Proc Natl Acad Sci USA 72: 3129–3133, 1975

    Google Scholar 

  169. Revel M, Bash D, Ruddle FII: Antibodies to cell surface component coded by human chromosome 21 inhibit action of interferon. Nature 260: 139–141, 1976

    Google Scholar 

  170. Slater DL, Shulman L, Lawrence JB, Revel M, Ruddle FH: Presence of human chromosome 21 alone is sufficient for hybrid cell sensitivity to human interferon J Virol 25: 319–325, 1978

    Google Scholar 

  171. DeClercq E, Edy VG, Cassiman JJ: Non-antiviral activities of interferon are not controlled by chromosome 21. Nature 256: 132–134. 1975

    Google Scholar 

  172. Tan YH: Chromosome 21 and the cell growth inhibitory effect of human interferon preparations. Nature 260: 141–143. 1976

    Google Scholar 

  173. Zhang Z-X, DeClercq E, Heremans H, Verhaegen-Lewalle M, Content J: Antiviral and anticellular activities of human and murine Type I and Type H interferons in human cells monosomic, disomic and trisomic for chromosome 21 (41405). Proc Soc Exp Biol Med 170: 103–111, 1982

    Google Scholar 

  174. Yonehara S, Yonehara-Takahashi M, Ishii A: Binding of human interferon-α to cells of different sensitivities: studies with internally radiolabelled interferon retaining full biological activity. J Virol 45: 1168–1171, 1983

    Google Scholar 

  175. Yonchara S, Yonchara-Takahashi M, Ishii A, Nagata S: Different binding of human interferon α1 and α2 to common receptors on human and bovine cells. J Biol Chem 258: 9046–9049. 1983

    Google Scholar 

  176. Aguct M, Grobke M, Dreiding P: Various human interferon α subclasses cross-react with common receptors: their binding affinities correlate with their specific biological activities. Virol 132: 211–216, 1984

    Google Scholar 

  177. Taylor-Papadimitriou J, Shearer M: Complex kinetics of binding of HuIFN-α2 to human but not bovine cells. J Inter Res 4: 553–559, 1984

    Google Scholar 

  178. Pestka S, Keldar B, Familletti PC, Moschera JA, Crowl R, Kempner ES: Molecular weight of the functional unit of human leukocyte fibroblast, and immune interferons. J Biol Chem 258: 9706–9709, 1983

    Google Scholar 

  179. Shire SJ: pH-dependent polymerisation of a human leukocyte interferon produced by recombinant deoxyribonucleic aicd technology. Biochem 22: 2664–2671, 1983

    Google Scholar 

  180. Eid P, Mogensen KE: Isolated interferon α receptor complexes stabilized in vitro. Febs Letts 156: 157–160, 1983

    Google Scholar 

  181. Mogensen KE, Bandu MT: Kinetic evidence for an activation step following binding of human interferon-α2 to the membrane receptors of Daudi cells. Eur J Biochem 134: 355–364, 1983

    Google Scholar 

  182. Aguet M, Blanchard B: High-affinity binding of 125I-labelled mouse interferon to a specific cell surface receptor. Virol 115: 249–261, 1981

    Google Scholar 

  183. Schechter AL, Bothwell MA: Nerve growth factor receptors on PC12 cells: evidence for two receptor classes with differing cytoskeletal association. Cell 24: 867–874, 1981

    Google Scholar 

  184. Thomas Y, Rogozinki L, Chess L: Relationship between human T cell functional heterogeneity and human T cell surface molccules. Immunol Reviews 74: 113–128, 1983

    Google Scholar 

  185. Farrar JJ, Benjamin WR, Steeg PS: Regulatory interactions between the interferons and the interleukins. In: Vilcek J, DcMacyer E (eds) Interferon 2, Elsevier Science Publishers, B.V., Amsterdam, 1984, pp 101–112

    Google Scholar 

  186. Epstein LB: Mitogen and antigen induction of interferon in vitro and in vivo. Tex Rep Biol Med 35: 42–56, 1977

    Google Scholar 

  187. DcMaeyer E, DeMacyer-Guignard J: Interferons as regulatory agents of the immune system. Critical Reviews in Immunol 1981, pp 167–188

  188. Stanton GJ, Langford MP, Weigent DA: Cell types involved in production of interferon by lcukocytes. Tex Rep Biol Med 41: 84–120, 1981

    Google Scholar 

  189. Wilkinson M, Morris AG: Interferon and the immune system. 1. Induction of interferon by stimulation of the immune system. Symp Soc Gen Microbiol 35, Cambridge University Press, Cambridge, 1983. pp 149–179

    Google Scholar 

  190. Wiranowska-Stewart M, StewartII WE: Determination of human lcukocyte populations involved in production of interferons alpha and gamma. J Interferon Res 1: 233–244, 1981

    Google Scholar 

  191. Rasmussen L, Merigan TC: Role of T lymphocytes in cellular immune responses during herpes simplex virus infection in humans. Proc Natl Acad Sci USA 75: 3957–3961, 1978

    Google Scholar 

  192. Trinchieri G, Santoli D, Knowles BB: Tumour cell clines induce interferon in human lymphocytes. Nature 270: 611–613, 1977

    Google Scholar 

  193. Timonen T, Saksela E, Virtanen I, Cantell K: Natural killer cells are responsible for the interferon production induced in human lymphocytes by tumour cell contact. Eur J Immunol 10: 422–427, 1980

    Google Scholar 

  194. Fischer DG, Rubinstein M: Spontancous production of interferon-gamma and acid-labile interferon-alpha by subpopulations of human mononuclear cells. Cell Immunol 81: 426–434, 1983

    Google Scholar 

  195. Cunningham AL, Merigan TC: Leu-3' T cells produce gmama-interferon in patients with recurrent herpes labialis. J Immunol 132: 197–202, 1984

    Google Scholar 

  196. Martinez-Maza O, Anderson U, Andersson J, Britton S, DeLey M: Spontaneous production of interferon-gamma in adult and new born humans. J Immunol 132: 251–255, 1984

    Google Scholar 

  197. Matsuyama M, Sugamura K, Kawade Y, Hinuma Y: Production of immune interferon by cytotoxic T cell clones. J Immunol 129: 450–451, 1982

    Google Scholar 

  198. Epstein LB, Goldblatt D, Yu K, Dean JH, Herberman RB, Oppenhcim JJ, Rocklin RE, Sugiyama M: Mediator induction in human mononuclear cells by strains of corynebacterium parvum. In: DeWeck AL (ed) Biochemical characterisation of lymphokines, Academic Press, Inc., New York, 1980, pp 353–358

    Google Scholar 

  199. Preble OT, Black RJ, Friedman RM, Klippel JH, Vilcek J: Systemic lupus erythematosus: presence in human sera of an unusual acid-labile leucocyte interferon. Science 216: 429–431, 1982

    Google Scholar 

  200. Trinchieri G, Santoli D Dee RR, Knowles BB: Antiviral activity induced by culturing lymphocytes with tumorderived or virus-transformed cells. J Exp Med 147: 1299–1312, 1978

    Google Scholar 

  201. Gronberg A, Kiessling R, Masucci G, Guevara LA, Eriksson E, Klein G: Gamma interferon (IFN-γ) produced during effector and target interactions renders target cells less susceptible to NK-cell-mediated lysis. Int J Cancer 32: 609–616, 1983

    Google Scholar 

  202. Gisler RH, Lindahl P, Gresser I: Effects of interferon on antibody synthesis in vitro. J Immunol 113: 438–444, 1974

    Google Scholar 

  203. Johnson HM, Smith BG, Baron S: Inhibition of the primary in vitro antibody response by interferon preparations. J Immunol 114: 403–409, 1975

    Google Scholar 

  204. Johnson HM, Bukovic JA, Baron S: Interferon inhibition of the primary in vitro antibody response to a thymusindependent antigen. Cell Immunol 20: 104–109, 1975

    Google Scholar 

  205. Sonnenfeld G, Mandel AD, Merigan TC: The immunosuppressive effect of Type II mouse interferon preparations on antibody production. Cell Immunol 34: 193–206, 1977

    Google Scholar 

  206. Johnson HM: Effect of interferon on antibody formation. Tex Rep Biol Med 41: 411–419, 1981

    Google Scholar 

  207. Moore M: Interferon and the immune system 2: effect of interferon on the immune system. Symp Soc Gen Microbiol 35, Cambridge University Press, Cambridge, 1983, pp 181–210

    Google Scholar 

  208. Zarling ZM: Effects of interferon and its inducers on lcucocytes and their immunologic functions. In: Came PE, Carter WA (eds) Handbook of Experimental Pharmacology 71, Springer-Verlag, Berlin 1984, pp 403–431

    Google Scholar 

  209. Choi YS, Lim KM, Sanders FK: Effect of interferon alpha on pokeweed mitogen-induced differentiation of human peripheral blood B lymphocytes. Cell Immunol 64: 20–28, 1981

    Google Scholar 

  210. Harfast B, Huddlestone JR, Casali P, Merigan TC, Oldstone MBA: Interferon acts directly on human B lymphocytes to modulate immunoglobulin synthesis. J Immunol 127: 2146–2150, 1981

    Google Scholar 

  211. Rodriguez MA, Prinz WA, Sibbitt WL, Bankhurst AD, Williams Jr RC: Alpha interferon increases immunoglobulin production in cultured human mononuclear lcukocytes. J Immunol 130: 1215–1219, 1983

    Google Scholar 

  212. Trinchieri G, Santoli D, Dee RR, Knowles BB: Antiviral activity induced by culturing lymphocytes with tumourderived or virus-transformed cells. J Exp Med 147: 1229–1312, 1978

    Google Scholar 

  213. Lotsova E, Savary CA, Gutterman JU, Hersh EM: Modulation of natural killer cell-mediated cytotoxicity by partially purified and cloned interferon-α. Cancer Res 42: 2480–2488, 1982

    Google Scholar 

  214. Trinchieri G, Santoli D: Antiviral activity induced by culturing lymphocytes with tumour-derived or virus-transformed cells. Enhancement of human natural killer cell activity by interferon and antagonistic inhibition of susceptibility of target cells to lysis. J Exp Med 147: 1314–1333, 1978

    Google Scholar 

  215. Trinchieri G, Granato D, Perussia B: Interferon induced resistance of fibroblasts to cytolysis mediated by natural killer cells: specificity and mechanism. J Immunol 126: 335–340, 1981

    Google Scholar 

  216. Pace JL, Russell SW, Torress BA, Johnson HM, Gray PW: Recombinant mouse γ interferon induces the priming step in macrophage activation for tumour cell killing. J Immunol 130: 2011–2013, 1983

    Google Scholar 

  217. Nathan CF, Murray HW, Wiebe ME, Rubin BY: Identification of interferon gamma as the lymphokine that activates human macrophage oxidative metabolism and antimicrobial activity. J Exp Med 158: 670–689, 1983

    Google Scholar 

  218. Klimpel GR, Fleischmann WR, Klimpel KD: Gamma interferon (IFNγ) and IFNα/β suppress murine myeloid colony formation (CFU-c): magnitude of suppression is dependent upon level of colony stimulating factor (CSF). J Immunol 129: 76–80, 1982

    Google Scholar 

  219. Herberman RB: Interferon and cytotoxic effector cells. In: Vilcek J, DeMaeyer E (eds) Interferon 2. Elsevier Science Publishers BV, Amsterdam. 1984, pp 61–84

    Google Scholar 

  220. Sonnenfeld G: Effects of interferon on antibody formation. In: Vilcek J, DeMaeyer E (eds) Interferon 2. Elsevier Science Publishers BV. Amsterdam. 1984, pp 85–99

    Google Scholar 

  221. Vogel SN, Friedman RM: Interferon and macrophages: activation and cell surface changes. In: Vilcek J, DeMaeyer E (eds) Interferon 2. Elsevier Science Publishers BV, Amsterdam 1984, pp 35–59

    Google Scholar 

  222. Hooks JJ, Detrick-Hooks B: Interferon in autoimmune diseases and other immunoregulatory disorders. In: Vilcek J, DeMaeyer E (eds) Interferon 2, Elsevier Science Publishers BV, Amsterdam 1984, pp 165–174

    Google Scholar 

  223. Bottazzo GF, Pujol-Borrell R, Hanafusa T, Feldman M: Role of aberrant HLA-DR expression and antigen presentation in induction of endocrine autoimmunity, Lancet 2: 1115–1118, 1983

    Google Scholar 

  224. Londei M, Lamb JR, Bottazzo GF, Feldman M: Epithelial cells expressing aberrant MHC class II determinants can present antigen to cloned human T cells. Nature 312: 639–641, 1984

    Google Scholar 

  225. Frayssinet C, Gresser I, Tovey M, Lindahl P: Inhibitory effect of potent interferon preparations on the regeneration of mouse liver after partial hepatectomy. Nature 245: 146–147, 1973

    Google Scholar 

  226. DeMacyer E, DeMaeyer-Guignard J: Effect of interferon on cell-mediated immunity. Tex Rep Biol Med 35: 370–374, 1977

    Google Scholar 

  227. DeMaeyer-Guignard J: Effects of interferon on cell-mediated immunity as manifested by delayed hypersensitivity and allograft rejcetion. In: Vilcek J, DeMaeyer E (eds) Interferon 2. Elsevier Science Publishers BV. Amsterdam 1984, pp 133–145

    Google Scholar 

  228. Schroder EW, Chou JN, Jaken S, Black PH: Interferon inhibits the release of plasminogen activator from SV3T3 cells. Nature 276: 828–829, 1978

    Google Scholar 

  229. Lee SHS, Epstein LB: Reversible inhibition by interferon of the maturation of human peripheral blood monocytes to macrophages. Cell Immunol 50: 177–190, 1980

    Google Scholar 

  230. StewartII WE, Gosser LB, Lockhardt RZ: Priming: a nonantiviral function of interferon. J Virol 7: 792–801, 1971

    Google Scholar 

  231. StewartII WE, DeClercq E, Billiau A, Desmyter J, DeSomer P: Incresed susceptibility of cells treated with interferon to the toxicity of polyriboinosinic-polyribocytidylic acid. Proc Natl Acad Sci USA 69: 1851–1854, 1972

    Google Scholar 

  232. Nebert DW, Friedman RM: Stimulation of aryl hydrocarbon hydroxylase induction in cell cultures by interferon. J Virol 11: 193–197, 1973

    Google Scholar 

  233. Donahoe RM, Huang K-Y: Interferon preparations enhance phagocytosis. Infect Immun 13: 1250–1257, 1976

    Google Scholar 

  234. Ida S, Hooks JJ, Siraganian RP, Notkins AB: Enhancement of IgE-mediated histamine release from human basophils by viruses: role of interferon. J Exp Med 145: 892–906, 1977

    Google Scholar 

  235. Yaron M, Yaron I, Gurani-Rotman D, Revel M, Linder HR, Zot U: Stimulation of prostaglandin E production in cultured human fibroblasts by polly(I)-poly(c) and human interferon. Nature 267: 457–459, 1977

    Google Scholar 

  236. Atallah AM, Needy CF, Noguchi PD, Elisberg BL: Enhancement of carcinoembryonic antigen expression by interferon. Int J Cancer 24: 49–52, 1979

    Google Scholar 

  237. Calvet M-C, Gresser I: Interferon enhances the excitability of cultured neurones. Nature 278: 558–560, 1979

    Google Scholar 

  238. Fridman WH, Gresser I, Bandu MT, Aguet M, Neaupor Sautes C: Inteferon enhances the expression of FCγ receptors. J Immunol 124: 2436–2441. 1980

    Google Scholar 

  239. Lotem J, Sacks L: Genetic dissociation of different cellular effects of interferon on myeloid leukemic cells. Int J Cancer 22: 214–220. 1978

    Google Scholar 

  240. Tomida M, Yamamoto Y, Hozumi M: Stimulation by interferon of induction of differentiation of mouse myeloid leukemic cells. Cancer Res 40: 2919–2924, 1980

    Google Scholar 

  241. Friedman RM, Kohn LD, Lee G, Epstein D, Jacobsen H: Stimulatory activity by mouse interferon on the uptake of iodide by rat thyroid cells. In: DeMaeyer G, Galasso G Schellekens H (eds) Biology of the Interferon System. Elsevier/North Holland Biomedical Press. Amsterdam 1981, pp 109–110

    Google Scholar 

  242. Dijkmans R, Billiau A: An introduction to the genes of the interferon system. In: Taylor-Papadimitriou J (ed) Interferons: their Impact in Science and Medicine, Oxford University Press. Oxford, 1985, pp 1–18

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. The Imperial Cancer Research Fund, Lincoln's Inn Fields, P.O. Box No. 123, WC2A 3PX, London, U.K.

    Moira Shearer & Joyce Taylor-Papadimitriou

Authors
  1. Moira Shearer
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Joyce Taylor-Papadimitriou
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Shearer, M., Taylor-Papadimitriou, J. Regulation of cell growth by interferon. Cancer Metast Rev 6, 199–221 (1987). https://doi.org/10.1007/BF00144264

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00144264

Keywords

Search

Navigation